Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2000
11/08/2000CN1272884A Adipocyte-specific protein homologs
11/08/2000CN1272879A Attenuated Japanese encephalitis virus adapted to vero cell and Japanese encephalitis vaccine
11/08/2000CN1272840A Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments
11/08/2000CN1272793A Method of protecting against chronic infections
11/08/2000CN1272792A Herbal extract composition and method with immune-boosting capability
11/08/2000CN1272546A New human neuronal protein and its coded sequence
11/08/2000CN1058296C Antibody heteroconjugates for use in regulation lymphocyte activity
11/08/2000CN1058191C 疫苗 Vaccine
11/07/2000US6143876 Immunogenic antigenic epitope which is a member of a binding couple; for production of antibodies with increased affinity; diagnosis; treatment; vaccines; viricides against human immunodeficiency virus
11/07/2000US6143872 Polypeptide encoded by dna having defined nucleotide sequence; early diagnosis of lyme disease using polymerase chain reaction primers; vaccines
11/07/2000US6143870 Thrombin receptor homolog
11/07/2000US6143730 As anti-angiogenic, anti-metastatic and/or anti-inflammatory agents
11/07/2000US6143551 Delivery of polypeptide-encoding plasmid DNA into the cytosol of macrophages by attenuated listeria suicide bacteria
11/07/2000US6143537 Reducing proteins susceptibility to degradation; mixing protein and immunoglobulin in solution, detecting degradation reducing complex
11/07/2000US6143527 Chain reaction cloning using a bridging oligonucleotide and DNA ligase
11/07/2000US6143493 HCMV-specific peptides, agents therefor and the use thereof
11/07/2000US6143306 Methods for treating pancreatic disorders
11/07/2000US6143305 Antigenically modified polypeptides composition
11/07/2000US6143299 Compositions and methods using complexes of heat shock protein gp96 and antigenic molecules for the treatment and prevention of infectious diseases
11/07/2000US6143297 Immunizing a mammals; forming antibodies
11/07/2000US6143296 Antibody 67D2
11/07/2000US6143292 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
11/07/2000US6143276 Methods for delivering bioactive agents to regions of elevated temperatures
11/07/2000US6143273 Useful as immunosuppressants, as well as antibodies capable of preventing the specific binding of the lag-3 protein to major histocompatibility complex class ii molecules as immunostimulants
11/07/2000CA2166981C Oncoprotein protein kinase
11/07/2000CA2075711C Vaccine and method therefor
11/07/2000CA2037933C Method of treatment with medical agents
11/07/2000CA1341133C Chlamydia major outer membrane protein
11/02/2000WO2000065078A1 A herpes simplex virus type 1 (hsv-1)-derived vector for selectively inhibiting malignant cells and methods for its use to treat cancers and to express desired traits in malignant and non-malignant mammalian cells
11/02/2000WO2000065069A1 Dsp-5 dual-specificity map kinase phosphatase
11/02/2000WO2000065068A1 Dsp-10 dual-specificity map kinsase phosphatase
11/02/2000WO2000065067A2 Prostate-specific polynucleotides, polypeptides and their methods of use
11/02/2000WO2000065064A1 Peptides and assays for the diagnosis of lyme disease and compositions useful for the prevention thereof
11/02/2000WO2000065063A2 Nucleic acid vaccines against rickettsial diseases and methods of use
11/02/2000WO2000065060A2 Dna sequence and recombinant production of a graminae allergen
11/02/2000WO2000065058A1 Method for down-regulating il5 activity
11/02/2000WO2000065057A1 Inhibition of viral infection using monovalent antigen-binding proteins
11/02/2000WO2000065043A1 Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension
11/02/2000WO2000065032A1 Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
11/02/2000WO2000064946A2 Compositions and methods for cancer treatment by selectively inhibiting vegf
11/02/2000WO2000064944A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains
11/02/2000WO2000064937A1 Inactivated cytokines for immunisation
11/02/2000WO2000064925A1 Method of inhibiting leukocyte adhesion to fibrinogen
11/02/2000WO2000064864A1 N-protected amines and their use as prodrugs
11/02/2000WO2000064488A2 Somatic transgene immunization and related methods
11/02/2000WO2000064479A1 Compositions containing tetracyclines for treating hemorrhagic virus infections and other disorders
11/02/2000WO2000064474A1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
11/02/2000WO2000064473A1 Composition for neuronal regeneration comprising myelin-specific antibodies and complement proteins
11/02/2000WO2000064471A1 Model membrane systems
11/02/2000WO2000064469A2 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds
11/02/2000WO2000064466A1 Localization of major peptide autoepitopes for nucleosome specific t cells of systemic lupus erythematosus
11/02/2000WO2000064465A1 Death domain containing receptors
11/02/2000WO2000064464A1 NUCLEIC ACIDS AND PROTEINS OF A RAT GANGLIOSIDE GM1-SPECIFIC αl→2FUCOSYLTRANSFERASE AND USES THEREOF
11/02/2000WO2000064458A2 Method for inducing a donor tolerance in the human body
11/02/2000WO2000064446A1 Noscapine derivatives as adjuvant compositions and methods of use thereof
11/02/2000WO2000064400A2 Methods for treating congestive heart failure
11/02/2000WO2000041726A3 Noninvasive vascular therapy
11/02/2000WO2000041516A3 Reagents and methods useful for detecting diseases of the breast
11/02/2000WO2000041508A3 Combination therapy of cancer by the activation of co-stimulatory molecules expressed by immune cells and cytokines
11/02/2000WO2000039299A3 Streptococcus antigens
11/02/2000WO2000039136A3 Human brainiac-5
11/02/2000WO2000038730A3 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
11/02/2000WO2000038712A3 Method for producing autogenous vaccines for treating chlamydial infections in mammals and humans
11/02/2000WO2000037640A9 Compositions and methods for the treatment of tumor
11/02/2000WO2000037504A9 Human monoclonal antibodies to ctla-4
11/02/2000WO2000029029A9 Compositions and methods for producing vascular occlusion
11/02/2000WO2000024876A3 Spumavirus isolated from humans
11/02/2000WO2000004926A3 Conjugates for treating inflammatory disorders and associated tissue damage
11/02/2000EP1048734A2 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use
11/02/2000EP1048728A1 Means and method for the prevention and or treatment of trypanosomosis
11/02/2000EP1048299A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies
11/02/2000EP1048298A2 Mixed chimerism and tolerance
11/02/2000EP1047787A1 Human calcineurin b-like protein
11/02/2000EP1047784A2 Neissera meningitidis antigens
11/02/2000EP1047776A2 Therapeutic composition comprising the kal protein and use of the kal protein
11/02/2000EP1047770A1 Histidine kinase
11/02/2000EP1047711A1 Nucleic acid sequences encoding capsaicin receptors
11/02/2000EP1047457A2 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE
11/02/2000EP1047449A1 Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration
11/02/2000EP1047448A1 Dna vaccines against tick-borne flaviviruses
11/02/2000EP1047447A1 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF $i(MORAXELLA) $i((BRANHAMELLA)) $i(CATARRHALIS) INFECTIONS IN MAMMALS
11/02/2000EP1047446A1 Vaccine composition for herpes simplex virus and methods of using
11/02/2000EP1047422A1 Use of histamine for elevating blood histamine levels
11/02/2000EP1047301A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv)
11/02/2000EP0683816B1 Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines
11/02/2000EP0662148B1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor
11/02/2000DE19549523C2 New proteins from porcine reproductive and respiratory syndrome virus
11/02/2000CA2650236A1 Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
11/02/2000CA2377135A1 Dsp-10 dual-specificity map kinsase phosphatase
11/02/2000CA2371592A1 Composition for neuronal regeneration comprising myelin-specific antibodies and complement proteins
11/02/2000CA2371114A1 Death domain containing receptors
11/02/2000CA2370643A1 Noscapine derivatives as adjuvant compositions and methods of use thereof
11/02/2000CA2370547A1 Dsp-5 dual-specificity map kinase phosphatase
11/02/2000CA2370404A1 Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension
11/02/2000CA2370391A1 Method for down-regulating il5 activity
11/02/2000CA2370351A1 Inhibition of viral infection using monovalent antigen-binding proteins
11/02/2000CA2370306A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains
11/02/2000CA2368205A1 N-protected amines and their use as prodrugs
11/02/2000CA2367830A1 Method of inhibiting leukocyte adhesion to fibrinogen
11/01/2000CN1272139A Nucleic acids coding for proteins capable of interacting with presenilins
1 ... 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 ... 1823